Europe Sulfadoxine Market, Outlook and Forecast 2025-2030
Europe Sulfadoxine Market, Outlook and Forecast 2025-2030
The Europe Sulfadoxine market was valued at US$ 125.4 million in 2024 and is projected to reach US$ 168.5 million by 2030, at a CAGR of 5.1%
Sulfadoxine is an antimicrobial medication used in combination therapy for treating and preventing malaria. This pharmaceutical compound features specific antimicrobial properties and established safety profile. Modern formulations include improved bioavailability and stability characteristics.
Pharmaceutical manufacturing leads with 52% market share, followed by veterinary (28%) and research (12%). Switzerland dominates with 38% share. Manufacturing standards improved 40% since 2022. R&D investment reached
